Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/27/26 16:13 | 12/15/25 | BCAX | Health | Drug | Pharmaceutical Preparations | Cohlhepp Ryan | MA | DO | P,COO | 7 | M.d | 524 | 9.32 | 0 | 56 | 36 | 214 | D | ||||||||||||||
2/27/26 16:13 | 12/15/25 | BCAX | Health | Drug | Pharmaceutical Preparations | Cohlhepp Ryan | MA | DO | P,COO | 7 | S.d | -524 | 9.32 | 0 | -56 | 214 | D | |||||||||||||||
1/26/26 16:33 | 12/22/25 | BCAX | Health | Drug | Pharmaceutical Preparations | Hyep Ivan | MA | O | CFO | 4 | M.d | 245 | 11.04 | 0 | 22 | 18 | 145 | D | ||||||||||||||
1/26/26 16:33 | 12/22/25 | BCAX | Health | Drug | Pharmaceutical Preparations | Hyep Ivan | MA | O | CFO | 4 | S.d | -245 | 11.04 | 0 | -22 | 145 | D | |||||||||||||||
12/29/25 17:10 | 12/26/25 | BCAX | Health | Drug | Pharmaceutical Preparations | Raben David | MA | O | Chief Me | 1 | M.d | 75 | 3.79 | 0 | 20 | 56 | 55 | D | ||||||||||||||
12/18/25 18:02 | 12/16/25 | BCAX | Health | Drug | Pharmaceutical Preparations | Mazumdar Claire | MA | DO | CEO | 1 | M.d | 161 | 5.45 | 0 | 30 | 10 | 339 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |